Anti-PKA beta (catalytic subunit) antibody,Abcam,AB187515

Host

Rabbit

Reactivity

Human

Application

ICC/IF, WB

Platform ID

BAB312071956

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-PKA beta (catalytic subunit) antibody
Cat. No.AB187515
HostRabbit
IsotypeIgG
ReactivityHuman
ApplicationICC/IF, WB
ClonalityPolyclonal
Concentration0.71 - 1.55 mg/mL Batch dependent concentration
ImmunogenRecombinant Full Length Protein corresponding to Human PRKACB.
PurityAffinity purification Immunogen
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.3 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine)
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Mediates cAMP-dependent signaling triggered by receptor binding to GPCRs (PubMed : 12420224, PubMed : 21423175, PubMed : 31112131). PKA activation regulates diverse cellular processes such as cell proliferation, the cell cycle, differentiation and regulation of microtubule dynamics, chromatin condensation and decondensation, nuclear envelope disassembly and reassembly, as well as regulation of intracellular transport mechanisms and ion flux (PubMed : 12420224, PubMed : 21423175). Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which binds and ubiquitinates these subunits, leading to their subsequent proteolysis (PubMed : 12420224, PubMed : 21423175). Phosphorylates GPKOW which regulates its ability to bind RNA (PubMed : 21880142). Acts as a negative regulator of mTORC1 by mediating phosphorylation of RPTOR (PubMed : 31112131). See full target information PRKACB

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.